Study on the corrosion behavior of polymeric nanocomposite coatings containing halloysite nanotubes loaded with multicomponent inhibitor

In the present study, the halloysite nanotubes (HNTs) were loaded with a multicomponent inhibitor (LHNT) comprising mainly benzotriazole (BTA), sodium benzoate (SB), and lauric acid (LA) via the vacuum cycling method. The successful loading of the BTA + LA + SB inhibitor has been confirmed by the TGA, FTIR, and BET analyses. The TGA analysis has determined ? 14% loading of the BTA + LA + SB into the HNTs. Moreover, UV-vis analysis shows that the time and pH-dependent have incremental release of the multicomponent inhibitor in various studied media. The composite coatings (LHNT COAT) were developed by reinforcing the 3 wt% of LHNTs into the epoxy matrix. The corrosion protection of the developed LHNT COAT was enhanced by 99.6% and 98.88% compared to the blank epoxy and unloaded HNT coatings, respectively. This improvement in the corrosion behavior can be attributed to the active release of the multicomponent inhibitor, as was also demonstrated by the electrochemical impedance spectroscopic (EIS) test. It is further predicted that the improved corrosion inhibition efficiency of LHNT COAT may be due to the formation of some components produced from the reaction of the inhibitor components or from the inhibitor reaction with the corrosive medium. The high corrosion resistance of LHNT COAT makes it attuned to several industrial applications.This publication was made possible by NPRP Grant 11S-1226-170132 and NPRP 13S-0120-200116 from the Qatar National Research Fund (a member of the Qatar Foundation). Statements made herein are solely the responsibility of the authors. The authors would like to thank the Central laboratory Unit (CLU), Qatar University, for SEM and TEM analyses.Scopu

Self-healing performance of smart polymeric coatings modified with tung oil and linalyl acetate

This work focuses on the synthesis and characterization of polymeric smart self-healing coatings. A comparison of structural, thermal, and self-healing properties of two different polymeric coatings comprising distinct self-healing agents (tung oil and linalyl acetate) is studied to elucidate the role of self-healing agents in corrosion protection. Towards this direction, urea-formaldehyde microcapsules (UFMCs) loaded with tung oil (TMMCs) and linalyl acetate (LMMCs) were synthesized using the in-situ polymerization method. The synthesis of both LMMCs and TMMCs under identical experimental conditions (900 rpm, 55◦C) has resulted in a similar average particle size range (63–125 µm). The polymeric smart self-healing coatings were developed by reinforcing a polymeric matrix separately with a fixed amount of LMMCs (3 wt.% and 5 wt.%), and TMMCs (3 wt.% and 5 wt.%) referred to as LMCOATs and TMCOATs, respectively. The development of smart coatings (LMCOATs and TMCOATs) contributes to achieving decent thermal stability up to 450◦C. Electrochemical impedance spectroscopy (EIS) analysis indicates that the corrosion resistance of smart coatings increases with increasing concentration of the microcapsules (TMMCs, LMMCs) in the epoxy matrix reaching ~1 GΩ. As a comparison, LMCOATs containing 5 wt.% LMMCs demonstrate the best stability in the barrier properties than other developed coatings and can be considered for many potential applications

Self-Healing Performance of Smart Polymeric Coatings Modified with Tung Oil and Linalyl Acetate

This work focuses on the synthesis and characterization of polymeric smart self-healing coatings. A comparison of structural, thermal, and self-healing properties of two different polymeric coatings comprising distinct self-healing agents (tung oil and linalyl acetate) is studied to elucidate the role of self-healing agents in corrosion protection. Towards this direction, urea-formaldehyde microcapsules (UFMCs) loaded with tung oil (TMMCs) and linalyl acetate (LMMCs) were synthesized using the in-situ polymerization method. The synthesis of both LMMCs and TMMCs under identical experimental conditions (900 rpm, 55 ◦C) has resulted in a similar average particle size range (63–125 µm). The polymeric smart self-healing coatings were developed by reinforcing a polymeric matrix separately with a fixed amount of LMMCs (3 wt.% and 5 wt.%), and TMMCs (3 wt.% and 5 wt.%) referred to as LMCOATs and TMCOATs, respectively. The development of smart coatings (LMCOATs and TMCOATs) contributes to achieving decent thermal stability up to 450◦C. Electrochemical impedance spectroscopy (EIS) analysis indicates that the corrosion resistance of smart coatings increases with increasing concentration of the microcapsules (TMMCs, LMMCs) in the epoxy matrix reaching ~1 GΩ. As a comparison, LMCOATs containing 5 wt.% LMMCs demonstrate the best stability in the barrier properties than other developed coatings and can be considered for many potential applications

Nanoparticles functionalized ceramic membranes: fabrication, surface modification, and performance

Membrane technologies are used intensively for desalination and wastewater treatment. Water filtration using ceramic membranes exhibited high performance compared with polymeric membranes due to various properties such as high resistance to fouling, permeability, rejection rate, and chemical stability. Recently, the performance of nanocomposite ceramic membranes was improved due to the development in nanotechnology. This article focusses on the development of porous ceramic membranes and nanomaterial functionalized ceramic membranes for water filtration applications. At the beginning, various fabrication methods of ceramic membranes were described, and the effect of surface modification techniques on the membrane intrinsic properties was reviewed. Then, the performance of nanoparticles functionalized ceramic membranes was evaluated in terms of physicochemical properties, rejection rate, and water permeability. This work can help new entrants and established researchers to become familiar with the current challenges and developments of nanoparticle-incorporated ceramic membranes for water filtration applications. 2021, Springer-Verlag GmbH Germany, part of Springer Nature.This publication was made possible by an Award (GSRA6-2-0516-19029) from Qatar National Research Fund (a member of Qatar Foundation). The contents herein are solely the responsibility of the author[s]. In addition, the authors wish to thank Qatar Foundation for the financial support provided to one of the co-authors through a graduate sponsorship research award (GSRA6-1-0509-19021). The authors wish to thank Qatar National Library (QNL) for the publication financial support.Scopu

Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries

© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 licenseBackground: 80% of individuals with cancer will require a surgical procedure, yet little comparative data exist on early outcomes in low-income and middle-income countries (LMICs). We compared postoperative outcomes in breast, colorectal, and gastric cancer surgery in hospitals worldwide, focusing on the effect of disease stage and complications on postoperative mortality. Methods: This was a multicentre, international prospective cohort study of consecutive adult patients undergoing surgery for primary breast, colorectal, or gastric cancer requiring a skin incision done under general or neuraxial anaesthesia. The primary outcome was death or major complication within 30 days of surgery. Multilevel logistic regression determined relationships within three-level nested models of patients within hospitals and countries. Hospital-level infrastructure effects were explored with three-way mediation analyses. This study was registered with ClinicalTrials.gov, NCT03471494. Findings: Between April 1, 2018, and Jan 31, 2019, we enrolled 15 958 patients from 428 hospitals in 82 countries (high income 9106 patients, 31 countries; upper-middle income 2721 patients, 23 countries; or lower-middle income 4131 patients, 28 countries). Patients in LMICs presented with more advanced disease compared with patients in high-income countries. 30-day mortality was higher for gastric cancer in low-income or lower-middle-income countries (adjusted odds ratio 3·72, 95% CI 1·70–8·16) and for colorectal cancer in low-income or lower-middle-income countries (4·59, 2·39–8·80) and upper-middle-income countries (2·06, 1·11–3·83). No difference in 30-day mortality was seen in breast cancer. The proportion of patients who died after a major complication was greatest in low-income or lower-middle-income countries (6·15, 3·26–11·59) and upper-middle-income countries (3·89, 2·08–7·29). Postoperative death after complications was partly explained by patient factors (60%) and partly by hospital or country (40%). The absence of consistently available postoperative care facilities was associated with seven to 10 more deaths per 100 major complications in LMICs. Cancer stage alone explained little of the early variation in mortality or postoperative complications. Interpretation: Higher levels of mortality after cancer surgery in LMICs was not fully explained by later presentation of disease. The capacity to rescue patients from surgical complications is a tangible opportunity for meaningful intervention. Early death after cancer surgery might be reduced by policies focusing on strengthening perioperative care systems to detect and intervene in common complications. Funding: National Institute for Health Research Global Health Research Unit

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licenseBackground: Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. Methods: A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Findings: Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Interpretation: Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. Funding: National Institute for Health and Care Research